RARECast: A Veteran Venture Capitalist Discusses Investing in Rare Disease Drug Development
September 6, 2017
Art Pappas, a former pharmaceutical executive turned venture capitalist, has spent more than 30 years working for and investing in drug companies. Among the areas he focuses on are rare disease drug developers. We spoke to Pappas about the changing climate for investment in rare disease companies, his thought process in evaluating potential investments, and at what point he considers exit strategies.
Sign up for updates straight to your inbox.